Sazi Imamoglu
Overview
Explore the profile of Sazi Imamoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satman I, Bennett H, Yilmaz C, Imamoglu S, Ayvaz G, Comlekci A, et al.
J Health Econ Outcomes Res
. 2023 Sep;
1(2):108-122.
PMID: 37662023
Type 2 diabetes mellitus (T2DM) poses a significant burden on population well being and healthcare expenditure in Turkey, with disease prevalence continuing to increase. Insulin treatment is necessary for patients...
2.
Gul C, Gul O, Cander S, Eroglu A, Hartavi M, Keni N, et al.
Ren Fail
. 2014 Jul;
36(8):1258-62.
PMID: 25020185
Aim: The prevalence of diabetes is increasing in elderly populations, and is thought to be an important risk factor for cognitive dysfunction in this age group. Methods: The study included...
3.
Cander S, Dizdar O, Gul O, Guclu M, Unal O, Tuncel E, et al.
Prim Care Diabetes
. 2014 Feb;
8(3):256-64.
PMID: 24522170
Aim: To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety. Methods: An open-label study performed at...
4.
Tuncel E, Erturk E, Ersoy C, Kiyici S, Duran C, Kuru N, et al.
J Sports Sci Med
. 2014 Feb;
3(1):49-54.
PMID: 24497821
While the best way to identify microalbuminuria is to determine albumin excretion rate (AER) in a 24 h urine sample. Published data have shown that calculation of an albumin/creatinine ratio...
5.
Cander S, Erturk E, Karkucak M, Gul O, Gorukmez O, Yakut T, et al.
Gene
. 2012 Sep;
509(1):158-63.
PMID: 22967707
The objective of this study was to investigate the effect of G870A gene polymorphism of CCND1 on the formation and behavioral features of prolactinomas. One hundred and thirteen patients with...
6.
Satman I, Imamoglu S, Yilmaz C
Diabetes Res Clin Pract
. 2012 Jun;
98(1):75-82.
PMID: 22652276
Aims: To evaluate physicians' adherence to guidelines by Diabetes Study Group of The Society of Endocrinology and Metabolism of Turkey (SEMT). Methods: The medical records of 1790 patients with type...
7.
Cander S, Gul O, Yildirim N, Unal O, Saraydaroglu O, Imamoglu S
J Diabetes Complications
. 2012 Mar;
26(1):65-7.
PMID: 22401876
Recurrent episodes of hypoglycemia in patients with diabetes are often associated with the ongoing treatment regimen. However, despite changes in treatment modalities, assessment of the causes of hypoglycemia in nondiabetic...
8.
Oz O, Kiyici S, Ersoy C, Cander S, Yorulmaz H, Gul C, et al.
Diabetes Res Clin Pract
. 2011 Aug;
94(2):212-6.
PMID: 21855160
Aim: Sitagliptin is not associated with weight gain and has neutral effects on body weight. It is unclear whether sitagliptin treatment alters serum ghrelin levels in people with type 2...
9.
Ersoy C, Sadikoglu G, Orhan H, Guclu M, Sarandol E, Akgun M, et al.
Cytokine
. 2010 Jan;
49(3):275-8.
PMID: 20045351
Obesity is the presence of either abnormal absolute amount or relative proportion of body fat. Contrary to gluteal obesity, visceral obesity is associated with different metabolic alterations including insulin resistance...
10.
Gul O, Tuncel E, Yilmaz Y, Ulukaya E, Gul C, Kiyici S, et al.
Metabolism
. 2009 Aug;
59(1):64-9.
PMID: 19709689
Low levels of soluble receptor for advanced glycation end products (sRAGE) have been associated with the occurrence of vascular complications in patients with type 2 diabetes mellitus. Preliminary evidence has...